
Amidst a wave of public criticism, Mariel Padilla has addressed concerns regarding her recent intravenous (IV) therapy session at the office of her husband, actor-turned-senator Robin Padilla.
The TV host-actress found herself under fire from netizens after sharing images of herself receiving an IV drip in Robin’s Senate office.
Padilla, who was at the Senate to support her husband following the passing of the Eddie Garcia Bill, later removed the photos in response to the backlash.
In an interview, she expressed acknowledgment of the criticism, saying, “Oo nga, dami ko bashers,” while clarifying that she had no intention of causing offense.
“In my heart Reg wala akong tinapakan na kahit sinong tao. Kung may na-offend sorry, pero walang intention na maka-offend. After the Eddie Garcia bill, hinintay ko si Robin. Mga 9 p.m. na ‘yun,” Padilla stated, addressing the controversy surrounding her actions. She explained that scheduling constraints led her to opt for the IV drip session in her husband’s office, expressing regret for any offense caused.
Padilla further remarked on the situation, humorously noting that she had another IV drip session while live-selling, seemingly in jest at the criticism she received. She reiterated her reasoning for choosing Robin’s office, citing her tardiness for her appointment with the drip services provider.
Senator Robin Padilla also weighed in on the issue, finding amusement in how the IV drip session became a “political issue.” He emphasized his wife’s promotion of health and wellness, stating, “My wife loves to promote good looks and good health,” in response to the controversy.
The controversy began when Padilla shared a now-deleted Instagram post on Thursday, Feb. 22, featuring her receiving an IV drip in her husband’s Senate office. The post, accompanied by a caption endorsing IV therapy, drew mixed reactions from the online community.
Subsequently, netizens expressed dismay over what they perceived as a lack of respect for the formality of the Senate office. Senator Nancy Binay acknowledged the concerns, stating that they would closely examine the matter due to its implications for the Senate’s reputation and health and safety protocols.